LABU Direxion Daily S&P Biotech Bull 3X Shares

*Unless otherwise stated, data provided by FactSet.

LABU Fund Description

LABU provides daily 3 times exposure to the S&P Biotechnology Select Industry Index.

LABU Factset Analytics Insight

LABU is a daily 3x leveraged bet on an equal-weighted index of US biotech stocks. The vast majority of the fund's exposure is to biotechnology and medical research but also captures significant exposure to pharmaceuticals as well. As a leveraged product, the fund is not a buy-and-hold investment. It gets its leverage exposure through a portfolio of derivatives contracts that gets rebalanced at the end of each trading day. Because of that, the fund's return for periods longer than a day becomes path-dependent and is likely to be different from 3x the return of the index for the same period. This makes LABU suitable primarily for short-term traders. Over time, compounding effects can lead to profound differences in expected returns relative to the index.

PERFORMANCE [as of 09/22/22] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS
LABU -28.80% 10.03% -81.11% -89.09% -44.31% -38.47% --
LABU (NAV) -28.58% 9.51% -81.06% -89.06% -44.33% -38.50% --
S&P Biotechnology Select Industry Index -9.06% 8.82% -30.11% -40.01% -1.70% -1.26% 9.49%
N/A -- -- -- -- -- -- --
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

LABU Summary Data

Direxion
05/28/15
Open-Ended Fund
0.96%
$894.08M
0.11%
N/A

LABU Portfolio Data

0.00%
N/A

LABU Index Data

Equal
Market Cap
N/A

LABU Fund Structure

Yes
Yes
-- / --
N/A
N/A
Low
3
Daily

LABU Tax Exposures

20.00% / 39.60%
--
No

LABU Factset Analytics Block Liquidity

As of 09/23/22
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of LABU. LABU is rated a 5 out of 5.

LABU Tradability

41,181,902
$382.13M
41,818,487
$380.98M
0.11%
$0.01
0.16%
1.17% / -3.95%
None
100.00%
50,000
836.37
0.01%
--
267,518
$6.79
5